Skip to content
Medical Health Aged Care

RACGP: Drug testing services save lives

Royal Australian College of GPs 3 mins read

The Royal Australian College of GPs (RACGP) has called on the Queensland Government to reverse course and back the state’s drug testing sites. 

It comes following reports today of the Queensland drug testing service CheQpoint detecting a third sample of the powerful and deadly synthetic opioid nitazene, which is even stronger than fentanyl and hundreds of times more potent than heroin. CheQpoint will shut its doors tomorrow after the Queensland Government opted to close two drug testing sites.  

RACGP President, Dr Michael Wright, urged the Queensland Government to reconsider closing the sites. 

“Drug testing services like CheQpoint save lives, and I call on the Government to support and fund these vital detection services,” he said. 

“It was only a year ago that the College welcomed the then Palaszczuk Government making Queensland the first Australian state or territory to introduce an ongoing drug testing service, and we urged other jurisdictions to follow suit. Since then, the service has tested over 1,000 drug samples and supported nearly 700 people with free and confidential health advice. No type of illicit drug use is ever safe, but we must follow the evidence. All governments should listen to the experts and put in place common sense measures to reduce drug-related harm and save lives.” 

RACGP Queensland Chair, Dr Cathryn Hester, backed the President’s calls. 

“The timing couldn’t be worse,” she said.  

“The new synthetic opioid nitazene, which is even more potent than fentanyl, has hit Australia’s shores and is often being sold to people as a legitimate pharmaceutical. Nitazene has been detected three times since November last year, and I strongly suspect we’re only scratching the surface.  

“Unlike other states and territories, Queensland doesn’t have an overdose monitoring system or a public drug alert network. I fear that once these drug testing services end, we will see more overdoses because the people taking them, including young people with their whole lives ahead of them, simply don’t know what they’re ingesting.  

“It’s not too late to reverse course. I appreciate that governments want to discourage illicit drug use, an objective shared by all GPs across Australia. However, it’s vital that policy makers listen to the experts and back policy measures that save lives. An independent evaluation of CheQpoint is due at the end of next month, and it would be wise to least review the expert evaluation before finalising the closure of these drug testing sites.” 

The College’s alcohol and other drugs spokesperson, Dr Marguerite Tracy, encouraged a health-based approach to substance use rather than a “war on drugs” mindset. 

“Drug testing sites like CheQpoint are a sensible harm reduction measure,” she said. 

“This is not about condoning illegal drug use, it’s about helping people who are taking illicit drugs make an informed decision. Healthcare workers at these sites also can talk to them about their drug use patterns and offer guidance and advice that could prove lifesaving. We know when people visit these sites, whether they be a ‘fixed’ service or a mobile service at events such as music festivals, many choose to dispose of their drugs once they’re told what they contain. 

“If you look around the world and what is happening in Australian jurisdictions, it’s clear Queensland is moving in the wrong direction. There is no point pretending that drug use doesn’t happen; it does happen, and we need to view alcohol and illicit drug use through a health lens.  Overdose deaths do not happen to ‘other people’, it could be your friend, child, or colleague. At the end of the day – every life matters.” 

~ENDS 

RACGP spokespeople are available for interviews: 03 8699 0992 / [email protected]. 


About us:

About the RACGP 

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians. 

Visit www.racgp.org.au. To unsubscribe from RACGP media releases, click here. 


Contact details:

Media team: 03 8699 0992 / [email protected] 

 

Follow us on Twitter: @RACGP and Facebook. 

 

Media

More from this category

  • Medical Health Aged Care
  • 29/04/2025
  • 17:40
Sinovac Biotech Ltd.

SINOVAC Board Issues Letter to Shareholders to Set the Record Straight on the Hostile Actions and False Claims by Vivo Capital

BEIJING--BUSINESS WIRE-- Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that its board of directors (the “Board”) issued a public letter to shareholders in response to hostile actions and false claims by Vivo Capital and certain other parties (the “Vivo group”) against the legitimate and lawful actions of the Board. Dear Shareholders, We are writing to set the record straight in response to the Vivo group’s recent press releases, lawsuits and other actions against SINOVAC and the Board, particularly those related to the Board’s decision to declare a cash…

  • Medical Health Aged Care
  • 29/04/2025
  • 16:41
Dementia Australia

Get active and beat dementia in the Gold Coast

The 2025 Gold Coast Memory Walk & Jog is nearly here with the event taking place on Sunday, 1 June at Pratten Park, Broadbeach. Dementia Australia’s largest annual fundraising event returns to the Gold Coast in the hopes of attracting our biggest crowd yet, with participants helping to raise funds in support of people living with dementia, their families and carers. Join MC’s Takaya Honda and Jess Redmayne for a wonderful fun, family friendly day out. Each event is a fantastic opportunity for people impacted by dementia and their supporters to come together to walk or run, raise much-needed funds…

  • Contains:
  • Medical Health Aged Care
  • 29/04/2025
  • 15:56
Microba Life Sciences Limited

Microba Delivers Landmark IBD Results & Signs Major Gastro Partner

Two independent clinical studies have demonstrated that Microba’s MetaPanel™ test identifies gastrointestinal pathogens in >35% of Inflammatory Bowel Disease (IBD) patients experiencing flare, with…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.